{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:39:30Z","timestamp":1648751970351},"reference-count":25,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"unspecified","delay-in-days":4086,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[1998]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article highlights factors that may cause bias in individual controlled trials or meta-analysis of zidovudine (AZT) in HIV disease. The overall benefit of AZT and antiretroviral drug combinations in the progression of HIV disease is probably greater than has been or can ever be shown in an ethical controlled trial.<\/jats:p>","DOI":"10.1017\/s0266462300011533","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T11:20:27Z","timestamp":1236684027000},"page":"567-572","source":"Crossref","is-referenced-by-count":0,"title":["Drugs for AIDS\/HIV:<i>Assessing the Evidence<\/i>"],"prefix":"10.1017","volume":"14","author":[{"given":"Jan L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"S0266462300011533_ref023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508173330701"},{"key":"S0266462300011533_ref021","first-page":"883","article-title":"Research, practice and the Cochrane Collaboration","volume":"152","author":"Robinson","year":"1995","journal-title":"Canadian Medical Association Journal"},{"key":"S0266462300011533_ref020","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510170083036"},{"key":"S0266462300011533_ref019","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520170077040"},{"key":"S0266462300011533_ref018","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-3-485"},{"key":"S0266462300011533_ref017","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199403000-00004"},{"key":"S0266462300011533_ref015","first-page":"1","article-title":"An introduction to assessing medical literature","volume":"9","year":"1995","journal-title":"MeReC Briefing"},{"key":"S0266462300011533_ref013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03270.x"},{"key":"S0266462300011533_ref012","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2532.1994.1140235.x"},{"key":"S0266462300011533_ref022","first-page":"15","article-title":"Correlation between viral load measurements and outcome in clinical trials of antiviral drugs","volume":"9","author":"Schooley","year":"1995","journal-title":"AIDS"},{"key":"S0266462300011533_ref014","doi-asserted-by":"publisher","DOI":"10.1136\/jech.48.1.6"},{"key":"S0266462300011533_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90006-X"},{"key":"S0266462300011533_ref024","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520060037029"},{"key":"S0266462300011533_ref007","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-10-727"},{"key":"S0266462300011533_ref005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430170067030"},{"key":"S0266462300011533_ref003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307293290501"},{"key":"S0266462300011533_ref025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004053221401"},{"key":"S0266462300011533_ref016","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.V78.4.900.900","article-title":"NHF-ACTG 36 Study Group. Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia","volume":"78","author":"Merigan","year":"1991","journal-title":"Blood"},{"key":"S0266462300011533_ref001","first-page":"557","article-title":"A method for assessing the quality of a randomized controlled trial","volume":"159","author":"Chalmers","year":"1981","journal-title":"Controlled Clinical Trials"},{"key":"S0266462300011533_ref004","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6982.752"},{"key":"S0266462300011533_ref006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707233170401"},{"key":"S0266462300011533_ref008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202133260703"},{"key":"S0266462300011533_ref009","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.69.817.867"},{"key":"S0266462300011533_ref010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-11-199506010-00009"},{"key":"S0266462300011533_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470190057029"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462300011533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T14:20:21Z","timestamp":1589638821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462300011533\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998]]}},"alternative-id":["S0266462300011533"],"URL":"https:\/\/doi.org\/10.1017\/s0266462300011533","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998]]}}}